These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 1613250)

  • 1. Tumour markers in oncology: past, present and future.
    Magdelénat H
    J Immunol Methods; 1992 Jun; 150(1-2):133-43. PubMed ID: 1613250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum cytokeratin fragment 21.1 (CYFRA 21.1) as tumour marker for breast cancer: comparison with carbohydrate antigen 15.3 (CA 15.3) and carcinoembryonic antigen (CEA).
    Giovanella L; Ceriani L; Giardina G; Bardelli D; Tanzi F; Garancini S
    Clin Chem Lab Med; 2002 Mar; 40(3):298-303. PubMed ID: 12005221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum tumour markers in lung cancer: history, biology and clinical applications.
    Ferrigno D; Buccheri G; Biggi A
    Eur Respir J; 1994 Jan; 7(1):186-97. PubMed ID: 8143820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic tumor diagnosis].
    Schmolke B
    Z Lymphol; 1990 Dec; 14(2):58-61. PubMed ID: 2087871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical usefulness of circulating tumor markers].
    Ohkura H
    Gan To Kagaku Ryoho; 2004 Jul; 31(7):1131-4. PubMed ID: 15272600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumour markers.
    Pandha HS; Waxman J; Sikora K
    Br J Hosp Med; 1994 Mar 16-Apr 5; 51(6):297-303. PubMed ID: 8032568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cell surface carbohydrates as prognostic markers in human carcinomas.
    Dabelsteen E
    J Pathol; 1996 Aug; 179(4):358-69. PubMed ID: 8869281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancers Screening in an Asymptomatic Population by Using Multiple Tumour Markers.
    Wang HY; Hsieh CH; Wen CN; Wen YH; Chen CH; Lu JJ
    PLoS One; 2016; 11(6):e0158285. PubMed ID: 27355357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of serum receptor-binding cancer antigen expressed on SiSo cells in gastrointestinal tract cancers.
    Coban S; Ozkan H; Köklü S; Yüksel O; Koçkar MC; Akar T; Ormeci N
    Can J Gastroenterol; 2006 Sep; 20(9):593-6. PubMed ID: 17001401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical applications of serum tumor markers.
    Bates SE
    Ann Intern Med; 1991 Oct; 115(8):623-38. PubMed ID: 1716430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Criteria of organ specificity of a tumor].
    Zolotarevskiĭ VB; Kogan EA
    Arkh Patol; 1984; 46(2):90-6. PubMed ID: 6370208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Tumor markers].
    Fiebiger W; Wiltschke C
    Acta Med Austriaca; 2001; 28(2):33-7. PubMed ID: 11382139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin glycoproteins as tumor markers.
    Feller WF; Henslee JG; Kinders RJ; Manderino GL; Tomita JT; Rittenhouse HG
    Immunol Ser; 1990; 53():631-72. PubMed ID: 2100576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioimmunoassays in oncology].
    Dressler J
    Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Early Cancer: Genetics or Immunology? Serum Autoantibody Profiles as Markers of Malignancy.
    Poletaev A; Pukhalenko A; Kukushkin A; Sviridov P
    Anticancer Agents Med Chem; 2015; 15(10):1260-3. PubMed ID: 26179267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced ovarian cancer. Tumour markers.
    Rustin GJ; van der Burg ME; Berek JS
    Ann Oncol; 1993; 4 Suppl 4():71-7. PubMed ID: 8312203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
    Hogdall EV; Høgdall CK; Tingulstad S; Hagen B; Nustad K; Xu FJ; Bast RC; Jacobs IJ
    Int J Cancer; 2000 Nov; 89(6):519-23. PubMed ID: 11102897
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumour-associated and differentiation antigens on the carbohydrate moieties of mucin-type glycoproteins.
    Feizi T; Gooi HC; Childs RA; Picard JK; Uemura K; Loomes LM; Thorpe SJ; Hounsell EF
    Biochem Soc Trans; 1984 Aug; 12(4):591-6. PubMed ID: 6208062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of multiple serum markers in patients with stage I ovarian cancer.
    Woolas RP; Xu FJ; Jacobs IJ; Yu YH; Daly L; Berchuck A; Soper JT; Clarke-Pearson DL; Oram DH; Bast RC
    J Natl Cancer Inst; 1993 Nov; 85(21):1748-51. PubMed ID: 8411259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human tumour-associated and tumour-specific antigens: some concepts in relation to clinical oncology.
    Neville AM; Mackay AM; Westwood J; Turberville C; Laurence DJ
    J Clin Pathol Suppl (Assoc Clin Pathol); 1975; 6():102-12. PubMed ID: 95631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.